Spouting Rock Asset Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-8,075
Closed -$239K 135
2023
Q3
$239K Buy
8,075
+1,769
+28% +$62.2K 0.08% 125
2023
Q2
$226K Buy
+6,306
New +$181K 0.08% 128
2022
Q4
Sell
-4,150
Closed -$223K 153
2022
Q3
$223K Buy
+4,150
New +$213K 0.17% 121
2021
Q3
Sell
-3,708
Closed -$460K 141
2021
Q2
$460K Buy
3,708
+430
+13% +$57.8K 0.14% 151
2021
Q1
$500K Sell
3,278
-3,146
-49% -$475K 0.15% 154
2020
Q4
$828K Buy
6,424
+2,403
+60% +$276K 0.26% 130
2020
Q3
$449K Buy
+4,021
New +$368K 0.21% 122

Other funds holding GH

Spouting Rock Asset Management's GH Position: Q4 2023 in Review

Spouting Rock Asset Management sold out of Guardant Health (GH) in Q4 2023, closing a stake of 8,075 shares — an estimated $239K sold.

Spouting Rock Asset Management first reported a position in GH in Q3 2020 and held it in 7 quarters. The position peaked at $828K in Q4 2020. 295 funds tracked by Wall St. Rank hold GH as of Q4 2023.

  • Spouting Rock Asset Management reported no remaining Guardant Health position as of Q4 2023 after selling out during the quarter.
  • Spouting Rock Asset Management sold 8,075 Guardant Health shares in Q4 2023, an estimated $239K.
  • Spouting Rock Asset Management first reported a position in Guardant Health in Q3 2020 and held it in 7 quarters.
  • Spouting Rock Asset Management's Guardant Health position peaked at $828K in Q4 2020.
  • 295 funds tracked by Wall St. Rank held Guardant Health as of Q4 2023.

Based on Spouting Rock Asset Management's 13F filing for Q4 2023, filed 16 Feb 2024.